Spark Therapeutics plans to invest $575 million to build a new gene therapy innovation center on Drexel University’s campus in Philadelphia’s University City neighborhood.
Through a 99-year ground lease of Drexel University’s F Lot, the new gene therapy center will be located at the intersection of 30th and Chestnut streets. The 500,000-square-foot, multistory facility is set to be a part of Spark’s now projected 1 million-square-foot campus in Philadelphia.
“Through this significant investment and plans to more than double our physical footprint, we’re poised for continued growth as we seek to develop the next generation of genetic medicines as a member of the Roche Group,” Jeff Marrazzo CEO and co-founder of Spark Therapeutics, said in a statement. “Since founding Spark eight years ago, Philadelphia has been part of our company’s DNA and we’re proud to continue to call Philadelphia home for many years to come.”
Spark Therapeutics is currently headquartered at 3737 Market St. in University City. Spark was acquired by Swiss multinational pharmaceutical company Roche in 2019, but it continues to operate as an independent company in Philadelphia.
For more information about Philadelphia medical space for sale or lease or about any other Philadelphia properties for sale or lease, please contact WCRE at 215-799-6900.
Wolf Commercial Real Estate, a full-service CORFAC International brokerage and advisory firm, is a premier Philadelphia medical commercial real estate broker that provides a full range of Philadelphia commercial real estate listings and services, property management services, and marketing commercial offices, medical properties, industrial properties, land properties, retail buildings and other Philadelphia commercial properties for buyers, tenants, investors, and sellers.
Please visit our websites for a full listing of Philadelphia commercial properties for lease or sale through our Philadelphia commercial real estate brokerage firm.
